Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/TCTR20210802002
TCTR20210802002CompletedPhase 4

A randomized controlled trial using nasal cannula to decrease hypoxia in pediatric patient during rapid sequence intubation compared with control group

Siriraj Research Development Fund, Faculty of Medicine, Siriraj Hospital,Mahidol University0 sites64 target enrollmentStarted: August 2, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
64
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 Days to 6 Years (—)
Sex
All

Inclusion Criteria

  • •1. ASA physical status between 1 to 3
  • •2. Scheduled for elective or emergency surgery under general anesthesia with rapid sequence induction and intubation.

Exclusion Criteria

  • •1. heart disease
  • •2. respiratory problems (either disease or obstruction)
  • •3. history or predicted difficult airway management
  • •4. fever (body temperature more than 37.5 Celsius degree)
  • •5. Allergies to drug use in the study

Investigators

Sponsor
Siriraj Research Development Fund, Faculty of Medicine, Siriraj Hospital,Mahidol University

Similar Trials

Completed
Not Applicable
A randomised controlled trial of nasal constant positive airway pressure (NCPAP) as primary therapy for respiratory distress syndrome (RDS) in very pre-term infants.eonatal Diseases: RespiratoryNeonatal DiseasesRespiratory
ISRCTN68552342Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)200
Completed
Not Applicable
A clinical trial to study the effects of different types of interfaces placed over nose on the safety and efficacy of non invasive ventilation in immature babies
CTRI/2020/07/026324Institute of Post Graduate Medical Education and Research Department of Neonatology210
Completed
Phase 2
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal NeuralgiaTrigeminal Neuralgia
NCT02473016Capnia, Inc.30
Completed
Phase 3
Study In Adults And Adolescents With Seasonal Allergic RhinitisHayfeverRhinitis, Allergic, SeasonalSeasonal Allergic Rhinitis
NCT00115622GlaxoSmithKline304
Not yet recruiting
Not Applicable
Oxygen therapy in covid positive patients
CTRI/2020/12/029803Sri venkateswara institute of medical sciences
A randomized controlled trial using nasal... | Clinical Trial